Literature DB >> 9344572

Transplantation of fetal neocortex ameliorates sensorimotor and locomotor deficits following neonatal ischemic-hypoxic brain injury in rats.

E M Jansen1, L Solberg, S Underhill, S Wilson, C Cozzari, B K Hartman, P L Faris, W C Low.   

Abstract

Ischemic brain injury in neonates can result in the degeneration of cortical and subcortical areas of brain and is associated with neurologic deficits. One approach to restoring function in conditions of ischemic brain injury is the use of neural transplants to repair damaged connections. This approach has been shown to reestablish neural circuitry and to ameliorate associated motor deficits in models of neonatal sensorimotor cortex damage. In this study, we utilized the Rice et al. rodent model of neonatal ischemic-hypoxic (IH) brain injury to assess whether transplantation of fetal neocortical tissue can promote functional recovery in tests of sensorimotor and locomotor ability throughout development and as adults. We show that animals that received neocortical grafts 3 days following the IH injury performed significantly better as adults on two measures of motor ability, the Rota-Rod treadmill and apomorphine-induced rotations, than did control animals that received sham transplants after the IH injury. Transplants were identifiable in 72% of the animals 10-12 weeks after implantation. Histochemical studies revealed that while the transplanted tissue did not establish normal cortical cytoarchitecture, cells and fibers within the grafts stained for nicotinamide adenine dinucleotide phosphate-diaphorase (NADPH-d), choline acetyl transferase (ChAT), cholecystokinin (CCK), and glial fibrillary acidic protein (GFAP). These results suggest that transplantation of fetal neocortical tissue following IH injury in the neonatal period is associated with amelioration of motor deficits and that the grafted tissue demonstrated a neurochemical phenotype that resembled normal neocortex. This approach warrants continued investigation in light of potential therapeutic uses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344572     DOI: 10.1006/exnr.1997.6596

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  9 in total

Review 1.  Stem cells for brain repair in neonatal hypoxia-ischemia.

Authors:  L Chicha; T Smith; R Guzman
Journal:  Childs Nerv Syst       Date:  2013-11-01       Impact factor: 1.475

2.  Transplanted neuroblasts differentiate appropriately into projection neurons with correct neurotransmitter and receptor phenotype in neocortex undergoing targeted projection neuron degeneration.

Authors:  J J Shin; R A Fricker-Gates; F A Perez; B R Leavitt; D Zurakowski; J D Macklis
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

Review 3.  Stem cells for ischemic brain injury: a critical review.

Authors:  Terry C Burns; Catherine M Verfaillie; Walter C Low
Journal:  J Comp Neurol       Date:  2009-07-01       Impact factor: 3.215

4.  Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats.

Authors:  Takao Yasuhara; Koichi Hara; Mina Maki; Robert W Mays; Robert J Deans; David C Hess; James E Carroll; Cesar V Borlongan
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-02       Impact factor: 6.200

Review 5.  The potential for cell-based therapy in perinatal brain injuries.

Authors:  Andre W Phillips; Michael V Johnston; Ali Fatemi
Journal:  Transl Stroke Res       Date:  2013-04       Impact factor: 6.829

Review 6.  Preclinical assessment of stem cell therapies for neurological diseases.

Authors:  Valerie L Joers; Marina E Emborg
Journal:  ILAR J       Date:  2009

7.  Embryonic amygdalar transplants in adult rats with motor cortex lesions: a molecular and electrophysiological analysis.

Authors:  Lydia Jiménez-Díaz; Mauricio O Nava-Mesa; Margarita Heredia; Adelaida S Riolobos; Marcelo Gómez-Álvarez; José María Criado; Antonio de la Fuente; Javier Yajeya; Juan D Navarro-López
Journal:  Front Neurol       Date:  2011-09-15       Impact factor: 4.003

Review 8.  Neonatal Hypoxia Ischaemia: Mechanisms, Models, and Therapeutic Challenges.

Authors:  Lancelot J Millar; Lei Shi; Anna Hoerder-Suabedissen; Zoltán Molnár
Journal:  Front Cell Neurosci       Date:  2017-05-08       Impact factor: 5.505

9.  Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial.

Authors:  Liem Thanh Nguyen; Anh Tuan Nguyen; Chinh Duy Vu; Doan V Ngo; Anh V Bui
Journal:  BMC Pediatr       Date:  2017-04-12       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.